past events
- 2019-
- ASA NJ Chapter 40th
annual Spring Symposium
- Statistical Considerations on Early-to-Late Transition of Oncology Projects - Cong Chen, Merck
- Innovation in Pediatric Trial Design in Rare Autoimmune Diseases - Peter Mesenbrink, Novartis
- A Case Study of Phase II/III Seamless Adaptive Design in a Rare Disease Area - Hui Quan, Sanofi
- Meta-Analysis of Rare Adverse Events in Randomized Clinical Trials: Bayesian and Frequentist Methods - Gary Rosner, Johns Hopkins University
- Incorporating Adult Clinical Data into Pediatric Clinical Trials: A Robust Bayesian Approach - Satrajit Roychoudhury, Pfizer
- Pediatric Drug Development – A Regulatory Perspective - James Travis, FDA
- History of spring Symposium - Poster by Steve Ascher
- ASA NJ Chapter 40th
annual Spring Symposium
- 2018-
- The 6th Annual ASA NJ Chapter/Bayer Statistics Workshop
- ASA NJ Chapter 39th annual Spring Symposium
- 2017-
- The 5th Annual ASA NJ Chapter/Bayer Statistics Workshop
- Joint Modeling of Time to Recurrence and Cancer Stage at Recurrence in Oncology Clinical Trials
- Moving beyond hazard ratio for quantifying the group difference in survival analysis
- Non-Proportional Hazards: What really matters from a public health perspective?
- The “Winratio” for Analysis of Clinical Trials with Multiple Outcomes
- Find the Posters Here
- ASA NJ Chapter 38th Annual Spring Symposium
- The Use of Rejection Odds And Rejection Ratios In Testing Hypotheses - Jim Berger, Duke University
- Examining Intuitions about Statistical Inference in Applied Research - Eric Loken, University of Connecticut
- Doctor, It Hurts When I p - Ron Wasserstein, ASA National Office
- New Perspectives of P-Value as Strength of Evidence Measured By Confidence Distribution- Minge Xie, Rutgers University
- Applying Additive P-Values Combinations Within Studies- Georgette Asherman
- Alternative Approaches To Regression Model, Which Is Almost Uniformly Applied To Many Different Types Of Clinical Trials-Michael Fundator
- The 5th Annual ASA NJ Chapter/Bayer Statistics Workshop
- 2016-
- The 4th Annual ASA NJ Chapter/Bayer Statistics Workshop
- Multiplicity and other issues related to biomarker-based oncology trials
- Conducting Meta-analysis under the Framework of Confidence Distribution Using gmeta Package in R
- Enhancing Clarity – Personal Remarks, a Short Review of the Estimands Concept, and a Current Discussion
- Increasing the Efficiency of Oncology Basket Trials using a Bayesian Approach
- ASA NJ Chapter 37th Annual Spring Symposium
- Basket Design of Phase III Confirmatory Trials - Cong Chen, Merck & Co. Inc.
- Value to Outcomes (V2O) in Oncology Drug Development - John Doyle, Quintiles, Columbia University
- Efficient Basket Trial Design for Single-Arm Phase II Trials- Mithat Gönen, Memorial Sloan Kettering Cancer Center
- Regulatory Challenges in Reviewing Oncology Product Applications- Kun He, FDA
- The Role of the Cancer Institute in Drug Development- Janice Mehnert MD, Rutgers Cancer Institute of New Jersey
- The 4th Annual ASA NJ Chapter/Bayer Statistics Workshop